(Q62820059)
Statements
A Phase 1, Open-label, Multicenter, Dose Escalation Study to Evaluate the Safety of a Single Intravitreal Injection of THR-149 for the Treatment of Diabetic Macular Edema (DME) (English)
0 references
18 May 2018
0 references
March 2019
0 references
12
0 references
18 year
0 references